Publication | Closed Access

Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase

Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug DesignBioavailable InhibitorsDrug DevelopmentβIi TryptasePharmacologyPharmaceutical ChemistryDrug Discovery